Superior Tolerability of Altered Dosing Schedule of Sunitinib with 2-Weeks-on and 1-Week-off in Patients with Metastatic Renal Cell Carcinoma--Comparison to Standard Dosing Schedule of 4-Weeks-on and 2-Weeks-off.

Bibliographic Details
Title:	Superior Tolerability of Altered Dosing Schedule of Sunitinib with 2-Weeks-on and 1-Week-off in Patients with Metastatic Renal Cell Carcinoma--Comparison to Standard Dosing Schedule of 4-Weeks-on and 2-Weeks-off.
Authors:	Tsunenori Kondo, Toshio Takagi, Hirohito Kobayashi, Junpei Iizuka, Taiji Nozaki, Yasunobu Hashimoto, Eri Ikezawa, Kazuhiko Yoshida, Kenji Omae, Kazunari Tanabe
Source:	Japanese Journal of Clinical Oncology; Mar2014, Vol. 44 Issue 3, p270-277, 8p
Database:	Complementary Index

More Details
ISSN:	03682811
DOI:	10.1093/jjco/hyt232
Published in:	Japanese Journal of Clinical Oncology
Language:	English